Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 07, 2024 08:55 ET | Source: Kronos Bio, Inc.

Kronos Bio Announces Selection of Autoimmune Development Candidate for Sjögren’s Disease

– KB-7898, a p300 KAT inhibitor, is the Company's first development candidate for autoimmune diseases and originates from its proprietary discovery engine that decodes complex transcription factor...